Cardiac sympathetic dysautonomia in children with chronic kidney disease

Journal of Nuclear Cardiology

Volumn 15, Issue 2, 2008, Pages 246-254

  Parisotto, Viviane ^a   Lima, Eleonora Moreira ^a   Silva, José Maria Penido ^a   de Sousa, Marcos Roberto ^a   Ribeiro, Antonio L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

autonomic nervous system; cardiac autonomic dysfunction; Chronic kidney disease; heart rate variability; iodine 123 metaiodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PARATHYROID HORMONE; TETROFOSMIN TC 99M;

ADOLESCENT; ADULT; ARTICLE; CARDIAC DYSAUTONOMIA; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; DYSAUTONOMIA; FEMALE; HEART LEFT VENTRICLE WALL; HEART RATE VARIABILITY; HEART SCINTISCANNING; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; UREMIA;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 40849104948     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2008.01.003     Document Type: Article

References (37)

1. Sarnak M.J., and Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35 Suppl 1 (2000) S117-S131
2. Kohlhagen J., and Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology (Carlton) 8 (2003) 274-279
3. Frankel A., Brown E., and Wingfield D. Management of chronic kidney disease. BMJ 330 (2005) 1039-1040
4. Kurata C., Wakabayashi Y., Shouda S., Okayama K., Yamamoto T., Ishikawa A., et al. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 36 (1995) 2037-2043
5. Kurata C., Uehara A., Sugi T., Ishikawa A., Fujita K., Yonemura K., et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84 (2000) 312-319
6. Miyanaga H., Yoneyama S., Kamitani T., Kawasaki S., Takahashi T., and Kunishige H. Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 3 Pt 1 (1996) 508-515
7. Kersh E.S., Kronfield S.J., Unger A., Popper R.W., Cantor S., and Cohn K. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290 (1974) 650-653
8. Ewing D.J., and Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 15 (1975) 424-429
9. Campese V.M., Kogosov E., and Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26 (1995) 861-865
10. London G.M., Fabiani F., Marchais S.J., De Vernejoul M.C., Guerin A.P., Safar M.E., et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 31 (1987) 973-980
11. Converse Jr. R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
12. Cloarec-Blanchard L., Girard A., Houhou S., Grunfeld J.P., and Elghozi J.L. Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int Suppl 37 (1992) S14-S18
13. Axelrod S., Lishner M., Oz O., Bernheim J., and Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 45 (1987) 202-206
14. Tory K., Sallay P., Toth-Heyn P., Szabo A., Szabo A., Tulassay T., et al. Signs of autonomic neuropathy in childhood uremia. Pediatr Nephrol 16 (2001) 25-28
15. Miltenyi G., Tory K., Stubnya G., Toth-Heyn P., Vasarhelyi B., Sallay P., et al. Monitoring cardiovascular changes during hemodialysis in children. Pediatr Nephrol 16 (2001) 19-24
16. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
17. Crawford M.H., Bernstein S.J., Deedwania P.C., DiMarco J.P., Ferrick K.J., Garson Jr. A., et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 34 (1999) 912-948
18. DePuey E.G., Port S., Wackers F.J., Rozanski A., Botvinick E.H., Dae M.W., et al. Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology. J Nucl Cardiol 5 (1998) 218-231
19. Morozumi T., Kusuoka H., Fukuchi K., Tani A., Uehara T., Matsuda S., et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 38 (1997) 49-52
20. Kurata C., Shouda S., Mikami T., Wakabayashi Y., Nakano T., Sugiyama T., et al. Comparison of [123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol 4 (1997) 515-523
21. Kurata C., Uehara A., and Ishikawa A. Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med 45 (2004) 1114-1120
22. Patel A.D., and Iskandrian A.E. MIBG imaging. J Nucl Cardiol 9 (2002) 75-94
23. Dae M.W., De Marco T., Botvinick E.H., O'Connell J.W., Hattner R.S., Huberty J.P., et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts-implications for clinical studies. J Nucl Med 33 (1992) 1444-1450
24. Tobes M.C., Fig L.M., Carey J., Geatti O., Sisson J.C., and Shapiro B. Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function. J Nucl Med 30 (1989) 1476-1482
25. Johnson T.S., Young J.B., and Landsberg L. Norepinephrine turnover in lung: effect of cold exposure and chronic hypoxia. J Appl Physiol 51 (1981) 614-620
26. Gillis C.N., and Pitt B.R. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 44 (1982) 269-281
27. Lee Y.S. Ultrastructural observations of chronic uremic lungs with special reference to histochemical and X-ray microanalytic studies on altered alveolocapillary basement membranes. Am J Nephrol 5 (1985) 255-266
28. Arao T., Takabatake N., Sata M., Abe S., Shibata Y., Honma T., et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med 44 (2003) 1747-1754
29. Simmons W.W., Freeman M.R., Grima E.A., Hsia T.W., and Armstrong P.W. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy. Circulation 89 (1994) 2843-2851
30. Gill J.S., Hunter G.J., Gane G., and Camm A.J. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 126 (1993) 390-398
31. Vita G., Bellinghieri G., Trusso A., Costantino G., Santoro D., Monteleone F., et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 56 (1999) 232-237
32. Lombardi F., Malliani A., Pagani M., and Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 32 (1996) 208-216
33. Malliani A., Lombardi F., and Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 71 (1994) 1-2
34. van de Borne P., Montano N., Pagani M., Oren R., and Somers V.K. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95 (1997) 1449-1454
35. Zoccali C., Mallamaci F., Parlongo S., Cutrupi S., Benedetto F.A., Tripepi G., et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105 (2002) 1354-1359
36. Neumann J., Ligtenberg G., Klein I.I., Koomans H.A., and Blankestijn P.J. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 65 (2004) 1568-1576
37. Zoccali C., Mallamaci F., and Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl (2003) S105-S110